No headlines found.
No press releases found.
No news found.
The Trust's primary investment objective is to seek to provide exposure to the value of Hyperliquid held by the Trust, less the expenses of the Trust's operations. The Trust's secondary investment objective is to seek to derive additional Hyperliquid through staking. The Trust will stake a portion of its Hyperliquid with the Hyperliquid Custodian. As consideration for participating in staking activities, the Trust will receive a portion of the reward generated from such participation in the form of additional Hyperliquid, which may be treated as income to the Trust. The additional Hyperliquid generated by the Trust's staking program will be subject to fees shared among the Staking Agent(s) and the Sponsor. The amounts owed or paid to the Staking Agent(s) and the Sponsor are collectively referred to as the "Staking Expenses". The Staking Expenses will equal 25% of the amount of the additional Hyperliquid generated by the staking of the Trust's Hyperliquid. The Trust will ultimately receive approximately 75% of the Hyperliquid generated by its staking activities.
Common Shares Of Beneficial Interest Of Bitwise Hyperliquid ETF trades on the ARCA stock market under the symbol BHYP.
As of July 9, 2026, BHYP stock price declined to $37.50 with 161,700 million shares trading.
BHYP has a market cap of $148.12 million. This is considered a Micro Cap stock.
BHYP support price is $35.63 and resistance is $40.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BHYP shares will trade within this expected range on the day.
